Edwards Lifesciences PE Ratio 2006-2021 | EW

Current and historical p/e ratio for Edwards Lifesciences (EW) from 2006 to 2021. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Edwards Lifesciences PE ratio as of September 23, 2021 is 54.64.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Edwards Lifesciences PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2021-09-23 121.02 51.94
2021-06-30 103.57 $2.33 44.45
2021-03-31 83.64 $1.35 61.96
2020-12-31 91.23 $1.30 70.18
2020-09-30 79.82 $1.25 63.86
2020-06-30 69.11 $1.16 59.41
2020-03-31 62.87 $1.74 36.07
2019-12-31 77.76 $1.65 47.23
2019-09-30 73.30 $1.22 60.25
2019-06-30 61.58 $1.14 54.18
2019-03-31 63.78 $1.20 53.30
2018-12-31 51.06 $1.12 45.45
2018-09-30 58.03 $1.17 49.60
2018-06-30 48.52 $1.08 44.93
2018-03-31 46.51 $0.93 50.19
2017-12-31 37.57 $0.96 39.14
2017-09-30 36.44 $1.15 31.78
2017-06-30 39.41 $1.10 35.83
2017-03-31 31.36 $1.01 31.15
2016-12-31 31.23 $0.87 35.76
2016-09-30 40.19 $0.84 47.65
2016-06-30 33.24 $0.80 41.30
2016-03-31 29.40 $0.78 37.62
2015-12-31 26.33 $0.75 35.18
2015-09-30 23.70 $0.70 33.77
2015-06-30 23.74 $0.67 35.52
2015-03-31 23.74 $1.35 17.63
2014-12-31 21.23 $1.25 16.94
2014-09-30 17.03 $1.20 14.19
2014-06-30 14.31 $1.17 12.25
2014-03-31 12.36 $0.46 27.07
2013-12-31 10.96 $0.57 19.23
2013-09-30 11.61 $0.59 19.84
2013-06-30 11.20 $0.57 19.70
2013-03-31 13.69 $0.53 26.00
2012-12-31 15.03 $0.41 36.50
2012-09-30 17.90 $0.37 48.14
2012-06-30 17.22 $0.35 49.66
2012-03-31 12.12 $0.33 36.54
2011-12-31 11.78 $0.33 35.89
2011-09-30 11.88 $0.33 36.00
2011-06-30 14.53 $0.33 44.71
2011-03-31 14.50 $0.33 44.62
2010-12-31 13.47 $0.30 44.41
2010-09-30 11.18 $0.28 39.90
2010-06-30 9.34 $0.32 29.40
2010-03-31 8.24 $0.31 27.01
2009-12-31 7.24 $0.32 22.32
2009-09-30 5.83 $0.31 18.64
2009-06-30 5.67 $0.26 22.23
2009-03-31 5.05 $0.24 20.77
2008-12-31 4.58 $0.18 24.98
2008-09-30 4.81 $0.15 31.92
2008-06-30 5.17 $0.14 35.88
2008-03-31 3.71 $0.14 27.34
2007-12-31 3.83 $0.16 24.73
2007-09-30 4.11 $0.16 25.55
2007-06-30 4.11 $0.16 25.97
2007-03-31 4.23 $0.16 26.56
2006-12-31 3.92 $0.17 22.62
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $74.587B $4.386B
Edwards Lifesciences Corporation provides products and technologies to treat late-stage cardiovascular disease. The Company's products include tissue replacement heart valves, heart valve repair products, hemodynamic monitoring devices, angioscopy equipment, oxygenators, and pharmaceuticals. Edwards Lifesciences Corporation is headquartered in Irvine, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $238.660B 23.76
ALCON INC (ALC) Switzerland $41.448B 45.89
STERIS (STE) Ireland $21.519B 32.68
Fresenius Medical Care AG KGaA (FMS) Germany $21.247B 14.86
Teleflex (TFX) United States $17.940B 31.32
Penumbra (PEN) United States $10.480B 298.42
Globus Medical (GMED) United States $8.028B 37.53
Nevro (NVRO) United States $4.337B 0.00
Integer Holdings (ITGR) United States $2.959B 27.59
Glaukos (GKOS) United States $2.386B 0.00
AVANOS MEDICAL, INC (AVNS) United States $1.547B 34.57
CryoLife (CRY) United States $0.933B 124.95